Summary
We tested the activity of low-molecular-weight enzyme inhibitors with immunomodifying actions on the suppression of experimental allergic encephalomyelitis (EAE). Of the agents tested the inhibitors of alkaline phosphatase, aminopeptidase B and esterase gave significant protection againts the clinical expression of EAE in guinea pigs.
References
Umezawa, H., in: Recent Results in Cancer Research, vol. 76, p. 767. Eds S. K. Carter, Y. Sakurai and H. Umezawa. Springer Verlag, Berlin 1981.
Holborow, E. J., and Swannel, A. J., in: Immunology in Medicine, p. 560. Eds E. J. Holborow and W. G. Reeves. Academic Press, London 1977.
Müller, W. E. G., Schuster, D. K., Maidhof, A., Leyhausen, G., Falke, D., and Umezawa, H., Int. J. Immunopharmac.4 (1982) 393.
Aoyagi, T., and Umezawa, H., in: Industrial and Clinical Enzymology, p. 89. Eds Lj. Vitale, and V. Simeon. Pergamon Press, Oxford 1980.
Yasuda, T., Tsumita, T., and Nagai, Y., Jap. J. exp. Med.45 (1975) 415.
Aoyagi, T., Wada, T., Ishikawa, Y., Kojima, F., Nagai, M., Osanai, T., Nagai, Y., and Umezawa, H., J. Pharm. Dyn.6 (1983) 963.
Aoyagi, T., Yamamoto, T., Kojiri, K., Kojima, F., Hamada, M., Takeuchi, T., and Umezawa, H., J. Antibiot.31 (1978) 244.
Umezawa, H., Aoyagi, T., Ohuchi, S., Okuyama, A., Suda, H., Takita, T., Hamada, M., and Takeuchi, T., J. Antibiot.36 (1983) 1572.
Umezawa, H., Aoyagi, T., Hazato, T., Uotani, K., Kojima, F., Hamada, M., and Takeuchi, T., J. Antibiot.31 (1978) 639.
Aoyagi, T., Tobe, H., Kojima, F., Hamada, M., Takeuchi, T., and Umezawa, H., J. Antibiot.31 (1978) 636.
Umezawa, H., Aoyagi, T., Uotani, K., Hamada, M., Takeuchi, T., and Takahashi, S., J. Antibiot.33 (1980) 1594.
Aoyagi, T., Wada, T., Iwabuchi, M., Kojima, F., Nagai, M., and Umezawa, H., Biochem. int.5 (1982) 97.
Brosnan, C. F., Cammer, W., Norton, W. T., and Bloom, B. R., Nature285 (1980) 235.
Van Belle, H., Biochim. biophys. Acta289 (1972) 158.
Oldham, R. K., and Smalley, R. V., J. Biol. Resp. Modif.2 (1983) 1.
Author information
Authors and Affiliations
Additional information
Acknowledgments. This work was partly supported by a grant-in-aid for New Drug Development Research from the Ministry of Health and Welfare, Japan.
Rights and permissions
About this article
Cite this article
Aoyagi, T., Wada, T., Nagai, M. et al. Low-molecular-weight enzyme inhibitors suppress the development of experimental allergic encephalomyelitis. Experientia 40, 1405–1407 (1984). https://doi.org/10.1007/BF01951914
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01951914